The stock of Klotho Neurosciences Inc. (KLTO) has seen a -8.70% decrease in the past week, with a -36.42% drop in the past month, and a -69.62% decrease in the past quarter. The volatility ratio for the week is 10.68%, and the volatility levels for the past 30 days are at 11.94% for KLTO. The simple moving average for the past 20 days is -28.17% for KLTO’s stock, with a -91.87% simple moving average for the past 200 days.
Is It Worth Investing in Klotho Neurosciences Inc. (NASDAQ: KLTO) Right Now?
The 36-month beta value for KLTO is also noteworthy at 0.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for KLTO is 16.49M, and at present, short sellers hold a 0.65% of that float. The average trading volume of KLTO on October 11, 2024 was 1.32M shares.
KLTO) stock’s latest price update
The stock of Klotho Neurosciences Inc. (NASDAQ: KLTO) has decreased by -5.35 when compared to last closing price of 0.52.Despite this, the company has seen a loss of -8.70% in its stock price over the last five trading days. prismmediawire.com reported 2024-09-30 that Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development New York, NY, September 30, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases and promoting healthy longevity, is proud to announce that Dr.
KLTO Trading at -44.94% from the 50-Day Moving Average
After a stumble in the market that brought KLTO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.24% of loss for the given period.
Volatility was left at 11.94%, however, over the last 30 days, the volatility rate increased by 10.68%, as shares sank -33.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -63.82% lower at present.
During the last 5 trading sessions, KLTO fell by -8.70%, which changed the moving average for the period of 200-days by -95.37% in comparison to the 20-day moving average, which settled at $0.6851. In addition, Klotho Neurosciences Inc. saw -95.40% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KLTO starting from CHARDAN CAPITAL MARKETS LLC, who sale 180,000 shares at the price of $2.05 back on Jul 02 ’24. After this action, CHARDAN CAPITAL MARKETS LLC now owns 1,284,364 shares of Klotho Neurosciences Inc., valued at $368,442 using the latest closing price.
CHARDAN CAPITAL MARKETS LLC, the 10% Owner of Klotho Neurosciences Inc., sale 115,136 shares at $2.06 during a trade that took place back on Jul 01 ’24, which means that CHARDAN CAPITAL MARKETS LLC is holding 1,464,364 shares at $237,618 based on the most recent closing price.
Stock Fundamentals for KLTO
Equity return is now at value -0.80, with -0.65 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.11.
Conclusion
In summary, Klotho Neurosciences Inc. (KLTO) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
